IU School of Medicine, BC Centre for Excellence in HIV/AIDS to jointly confront Indiana HIV outbreak
Jan 11, 2016 14:09 pm UTC| Business
VANCOUVER, Jan. 11, 2016 (GLOBE NEWSWIRE) -- The Indiana University (IU) School of Medicine and the BC Centre for Excellence in HIV/AIDS (BC-CfE) have joined forces to respond to a highly concentrated HIV epidemic driven...
General Cannabis Corporation Launches Chiefton Design
Jan 11, 2016 14:07 pm UTC| Business
DENVER, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Chiefton Supply Co. (Chiefton), a wholly owned subsidiary of General Cannabis Corporation (OTCQB:CANN), announces the official release of their cannabis design agency website,...
Jan 11, 2016 14:05 pm UTC| Business
MINNEAPOLIS, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Cachet Financial Solutions, Inc. (OTCQB:CAFN), a leading financial technology provider of cloud-based mobile money management solutions to banks, credit unions and other...
Manhattan Associates Powers Asda’s New ‘Game Changing’ Omni-channel Offering
Jan 11, 2016 14:00 pm UTC| Business
Manhattan provides technology for first-of-its-kind fulfillment and return service “toyou” LONDON and ATLANTA, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Manhattan Associates, Inc. (NASDAQ:MANH) today announced its pivotal...
Inteliquent Expands Leadership Team, Hires Michelle Owczarzak as Senior Vice President, Sales
Jan 11, 2016 14:00 pm UTC| Business
CHICAGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Inteliquent, Inc. (NASDAQ:IQNT), the carrier for communication service providers, announced today that its Board of Directors appointed Michelle Owczarzak as its Senior Vice...
LivaNova PLC Announces Approval of Perceval
Jan 11, 2016 14:00 pm UTC| Business
LONDON, Jan. 11, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”) announced that, on January 8, 2016, the Company received approval from the United States Food and Drug Administration...
Rexahn Pharmaceuticals’ Archexin® Shows Dose-Dependent Tumor Reduction in a Phase IIa Clinical Study
Jan 11, 2016 14:00 pm UTC| Business
ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced...